Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry

被引：0
|
作者：
Garcia Vega, D. [1 ]
Cinza-Sanjurjo, S. [2 ]
Eiras, S. [3 ,4 ]
Gonzalez-Juanatey, J. R. [1 ]
机构：
[1] Univ Hosp Santiago de Compostela, Santiago De Compostela, Spain
[2] Ctr Salud Milladoiro, Area Sanitaria Santiago de Compostela, Santiago De Compostela, Spain
[3] Hlth Res Inst Santiago de Compostela, Santiago De Compostela, Spain
[4] CIBERCV, Santiago De Compostela, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：591 / 591
页数：1
相关论文
共 50 条
  • [31] Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes
    Zareini, Bochra
    Gerds, Thomas A.
    Sorensen, Kathrine K.
    Clemmensen, Kim K. B.
    Kvist, Kajsa
    David, Jens-Peter
    Torp-Pedersen, Christian
    DIABETES, 2023, 72
  • [32] Gestione degli effetti collaterali delle terapie con SGLT2i e GLP1 RA
    Luigi Bonifazi Meffe
    Silvia Migliaccio
    Nicola Napoli
    Giuseppe Defeudis
    L'Endocrinologo, 2024, 25 (4) : 452 - 455
  • [33] Eligibility and Utilization of SGLT2i and GLP1-RA in T2D by Cardiovascular and Renal Indications
    Blood, Alexander
    Chang, Lee-Shing
    Colling, Caitlin A.
    Gabovitch, Daniel
    Hamersky, Carol M.
    Durden, Emily
    Holt, Cassie
    Noone, Joshua
    Cannon, Christopher P.
    Wexler, Deborah J.
    Scirica, Benjamin M.
    Waterman, Fanta
    Stern, Gretchen
    Zelle, David
    DIABETES, 2022, 71
  • [34] Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice
    Fu, Edouard L.
    Clase, Catherine M.
    Janse, Roemer J.
    Lindholm, Bengt
    Dekker, Friedo W.
    Jardine, Meg J.
    Carrero, Juan-Jesus
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 352 : 172 - 179
  • [35] Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
    Ritsinger, Viveca
    Avander, Kamila
    Lagerqvist, Bo
    Lundman, Pia
    Norhammar, Anna
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [36] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I197 - I198
  • [37] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [38] The Difference in the Effects on Microalbuminuria Depending on the Order of GLP-1RA and SGLT2i Therapy in Type 2 Diabetes
    Ohara, Masaya
    Motoyama, Koka
    Tamai, Anna
    Sakura, Takeshi
    Yakushiji, Yosuke
    Hosoi, Masayuki
    DIABETES, 2019, 68
  • [39] Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
    Koike, Masao
    Saito, Hitoki
    Kohno, Genta
    Takubo, Masahiro
    Watanabe, Kentaro
    Ishihara, Hisamitsu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [40] The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers
    Ikonomidis, I.
    Thymis, J.
    Pavlidis, G.
    Birba, D.
    Kalogeris, A.
    Kousathana, F.
    Kountouri, A.
    Korakas, E.
    Kostelli, G.
    Triantafyllou, C.
    Triantafyllidi, H.
    Andreadou, I.
    Lambadiari, V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2959 - 2959
12345